Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Long-term continuous sildenafil treatment ameliorates corporal veno-occlusive dysfunction (CVOD) induced by cavernosal nerve resection in rats

International Journal of Impotence Research volume 20, pages 202–212 (2008)Cite this article

Abstract

It was recently reported in the rat that vardenafil given in a continuous long-term manner was successful in preventing smooth muscle fibrosis in the penile corpora cavernosa and corporal veno-occlusive dysfunction (CVOD) that occur following bilateral cavernosal nerve resection (BCNR), a model for human erectile dysfunction after radical prostatectomy. To expand on this finding and to determine whether this effect was common to other PDE5 inhibitors, and occurred in part by stimulation of the spontaneous induction of inducible nitric oxide synthase (iNOS, also known as NOS2), male Fischer 344 rats (N=10/group) were subjected to either BCNR or unilateral cavernosal nerve resection (UCNR) and treated with sildenafil (20 mg kg−1 day−1) in the drinking water daily for 45 days. Additional BCNR groups received L-NIL (6.7 mg kg−1 day−1) as inhibitor of iNOS activity, with or without concurrent sildenafil administration. It was determined that sildenafil, like vardenafil, (1) prevented the 30% decrease in the smooth muscle cell/collagen ratio, and the 3–4-fold increase in apoptosis and reduction in cell proliferation, and partially counteracted the increase in collagen, seen with both UCNR and BCNR; and (2) normalized the CVOD, measured by dynamic infusion cavernosometry, induced by both BCNR and UCNR. The long-term inhibition of iNOS activity exacerbated corporal fibrosis and CVOD in the BCNR rats, but sildenafil functional effects were not affected by L-NIL. These data suggest that the salutary effects of continuous long-term PDE5 inhibitors on erectile function post-cavernosal nerve resection involve their ability to prevent the alterations in corporal histology induced by cavernosal nerve damage, in a process apparently independent from endogenous iNOS induction.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  1. Montorsi F, Burnett AL . Erectile dysfunction after radical prostatectomy. BJU Int 2004; 93: 1–2.

    Article  CAS  Google Scholar 

  2. Menon M, Kaul S, Bhandari A, Shrivastava A, Tewari A, Hemal A . Potency following robotic radical prostatectomy a questionnaire based analysis of outcomes after conventional nerve sparing and prostatic fascia sparing techniques. J Urol 2005; 174: 2291–2296.

    Article  Google Scholar 

  3. Montorsi F, McCullough A . Efficacy of sildenafil citrate in men with erectile dysfunction following radical prostatectomy: a systematic review of clinical data. J Sex Med 2005; 2: 658–667.

    Article  CAS  Google Scholar 

  4. Mulhall JP, Slovick R, Hotaling J, Aviv N, Valenzuela R, Waters WB et al. Erectile dysfunction after radical prostatectomy hemodynamic profiles and their correlation with the recovery of erectile function. J Urol 2002; 167: 1371–1375.

    Article  Google Scholar 

  5. Gonzalez-Cadavid NF, Ignarro LJ, Rajfer J . Nitric oxide and the cyclic GMP system in the penis. Mol Urol 1999; 3: 51–59.

    CAS  PubMed  Google Scholar 

  6. Iacono F, Giannella R, Somma P, Manno G, Fusco F, Mirone V . Histological alterations in cavernous tissue after radical prostatectomy. J Urol 2005; 173: 1673–1676.

    Article  Google Scholar 

  7. Schwartz EJ, Wong P, Graydon RJ . Sildenafil preserves intracorporeal smooth muscle after radical retropubic prostatectomy. J Urol 2004; 171: 771–774.

    Article  Google Scholar 

  8. Yaman O, Yilmaz E, Bozlu M, Anafarta K . Alterations of intracorporeal structures in patients with erectile dysfunction. Urol Int 2003; 71: 87–90.

    Article  Google Scholar 

  9. Gonzalez-Cadavid NF, Rajfer J . Molecular pathophysiology and gene therapy of aging-related erectile dysfunction. Exptl Gerontol 2004; 39: 1705–1712.

    Article  CAS  Google Scholar 

  10. Montorsi F, Briganti A, Salonia A, Rigatti P, Burnett AL . Current and future strategies for preventing and managing erectile dysfunction following radical prostatectomy. Eur Urol 2004; 45: 123–133.

    Article  Google Scholar 

  11. Davila HH, Rajfer J, Gonzalez-Cadavid NF . Corporal veno-occlusive dysfunction in the aging rat evaluation by cavernosometry and cavernosography. Urology 2004; 64: 1261–1266.

    Article  CAS  Google Scholar 

  12. Ferrini MG, Kovanecz I, Sanchez S, Vernet D, Davila HH, Rajfer J et al. Long-term continuous treatment with sildenafil in the rat ameliorates aging-related erectile dysfunction and the underlying corporal fibrosis. Biol Reprod 2007; 76: 915–923. epub ahead of print.

    Article  CAS  Google Scholar 

  13. Kovanecz I, Ferrini MG, Vernet D, Nolazco G, Rajfer J, Gonzalez-Cadavid NF . Pioglitazone prevents corporal veno-occlusive dysfunction (CVOD) in a rat model of type 2 diabetes mellitus. BJU Int 2006; 98: 116–124.

    Article  CAS  Google Scholar 

  14. Khatib AM, Siegfried G, Messai H, Moldovan F, Mitrovic DR . Mechanism of inhibition of endothelin-1-stimulated proteoglycan and collagen synthesis in rat articular chondrocytes. Cytokine 2002; 17: 254–261.

    Article  CAS  Google Scholar 

  15. Wang S, Wu X, Lincoln TM, Murphy-Ullrich JE . Expression of constitutively active cGMP-dependent protein kinase prevents glucose stimulation of thrombospondin 1 expression and TGF-beta activity. Diabetes 2003; 52: 2144–2150.

    Article  CAS  Google Scholar 

  16. Saura M, Zaragoza C, Herranz B, Griera M, Diez-Marques L, Rodriguez-Puyol D et al. Nitric oxide regulates transforming growth factor-beta signaling in endothelial cells. Circ Res 2005; 97: 1115–1123.

    Article  CAS  Google Scholar 

  17. Li P, Oparil S, Novak L, Cao X, Shi W, Lucas JA et al. ANP signaling inhibits TGF {beta}-induced Smad2 and Smad3 nuclear translocation and extracellular matrix expression in rat pulmonary arterial smooth muscle cells. J Appl Physiol 2006; 102: 390–398 epub ahead of print.

    Article  Google Scholar 

  18. Nagel DJ, Aizawa T, Jeon KI, Liu W, Mohan A, Wei H et al. Role of nuclear Ca2+/calmodulin-stimulated phosphodiesterase 1A in vascular smooth muscle cell growth and survival. Circ Res 2006; 98: 777–784.

    Article  CAS  Google Scholar 

  19. Pan SL, Guh JH, Chang YL, Kuo SC, Lee FY, Teng CM . YC-1 prevents sodium nitroprusside-mediated apoptosis in vascular smooth muscle cells. Cardiovasc Res 2004; 61: 152–158.

    Article  CAS  Google Scholar 

  20. Das A, Xi L, Kukreja RC . Phosphodiesterase-5 inhibitor sildenafil preconditions adult cardiac myocytes against necrosis and apoptosis. Essential role of nitric oxide signaling. J Biol Chem 2005; 280: 12944–12955.

    Article  CAS  Google Scholar 

  21. Gobeil Jr F, Zhu T, Brault S, Geha A, Vazquez-Tello A, Fortier A et al. Nitric oxide signaling via nuclearized endothelial nitric-oxide synthase modulates expression of the immediate early genes iNOS and mPGES-1. J Biol Chem 2006; 281: 16058–16067.

    Article  CAS  Google Scholar 

  22. Hayden MA, Nakayama DK . Cyclic nucleotides and inducible nitric oxide synthesis in pulmonary artery smooth muscle. J Surg Res 1999; 82: 222–227.

    Article  CAS  Google Scholar 

  23. Perez-Sala D, Cernuda-Morollon E, Diaz-Cazorla M, Rodriguez-Pascual F, Lamas S . Posttranscriptional regulation of human iNOS by the NO/cGMP pathway. Am J Physiol Renal Physiol 2001; 280: F466–F473.

    Article  CAS  Google Scholar 

  24. Hochberg D, Johnson CW, Chen J, Cohen D, Stern J, Vaughan Jr ED et al. Interstitial fibrosis of unilateral ureteral obstruction is exacerbated in kidneys of mice lacking the gene for inducible nitric oxide synthase. Lab Invest 2000; 80: 1721–1728.

    Article  CAS  Google Scholar 

  25. Chen Y, Hozawa S, Sawamura S, Sato S, Fukuyama N, Tsuji C et al. Deficiency of inducible nitric oxide synthase exacerbates hepatic fibrosis in mice fed high-fat diet. Biochem Biophys Res Commun 2005; 326: 45–51.

    Article  CAS  Google Scholar 

  26. Ferrini MG, Vernet D, Magee TR, Shahed A, Quian A, Rajfer J et al. Antifibrotic role of inducible nitric oxide synthase (iNOS). Nitric Oxide 2002; 6: 1–12.

    Article  Google Scholar 

  27. Davila HH, Magee TR, Rajfer J, Gonzalez-Cadavid NF . Gene therapy with the inducible nitric oxide synthase (iNOS) cDNA regresses the fibrotic plaque in an animal model of Peyronie's disease. Biol Reprod 2004; 71: 1568–1577.

    Article  CAS  Google Scholar 

  28. Gonzalez-Cadavid NF, Rajfer J . The pleiotropic effects of inducible nitric oxide synthase on the physiology and pathology of penile erection. Curr Pharm Des 2005; 11: 4041–4046.

    Article  CAS  Google Scholar 

  29. Ferrini MG, Davila H, Valente EG, Gonzalez-Cadavid NF, Rajfer J . Aging-related induction of inducible nitric oxide synthase (NOS2A) is vasculo-protective in the arterial media. Cardiovasc Res 2004; 61: 796–805.

    Article  CAS  Google Scholar 

  30. Zhang JJ, Bledsoe G, Kato K, Chao L, Chao J . Tissue kallikrein attenuates salt-induced renal fibrosis by inhibition of oxidative stress. Kidney Int 2004; 66: 722–732.

    Article  CAS  Google Scholar 

  31. Hewitson TD, Martic M, Darby IA, Kelynack KJ, Bisucci T, Tait MG et al. Intracellular cyclic nucleotide analogues inhibit in vitro mitogenesis and activation of fibroblasts derived from obstructed rat kidneys. Nephron Exp Nephrol 2004; 96: e59–e66.

    Article  CAS  Google Scholar 

  32. Vernet D, Ferrini MG, Valente E, Magee TR, Bou-Gharios G, Rajfer J et al. Effect of nitric oxide on fibroblast differentiation into myofibroblasts in cell cultures from the Peyronie's fibrotic plaque and in its rat model in vivo. Nitric Oxide 2002; 7: 262–276.

    Article  CAS  Google Scholar 

  33. Klein LT, Miller MI, Buttyan R, Raffo AJ, Burchard M, Devris G et al. Apoptosis in the rat penis after penile denervation. J Urol 1997; 158: 626–630.

    Article  CAS  Google Scholar 

  34. User HM, Hairston JH, Zelner DJ, McKenna KE, McVary KT . Penile weight and cell subtype specific changes in a post-radical prostatectomy model of erectile dysfunction. J Urol 2003; 169: 1175–1179.

    Article  Google Scholar 

  35. Leungwattanakij S, Bivalacqua TJ, Usta MF, Yang DY, Hyun JS, Champion HC et al. Cavernous neurotomy causes hypoxia and fibrosis in rat corpus cavernosum. J Androl 2003; 24: 239–249.

    Article  Google Scholar 

  36. Ferrini MG, Davila HH, Kovanecz I, Sanchez SP, Gonzalez-Cadavid NF, Rajfer J . Vardenafil prevents fibrosis and loss of corporal smooth muscle that occurs after bilateral cavernosal nerve resection in the rat. Urology 2006; 68: 429–435.

    Article  Google Scholar 

  37. Ferrini MG, Kovanecz I, Nolazco G, Rajfer J, Gonzalez-Cadavid NF . Effects of long-term treatment with vardenafil on the development of the fibrotic plaque in a rat model of Peyronie's disease. BJU Int 2006; 97: 625–633.

    Article  CAS  Google Scholar 

  38. Valente EG, Vernet D, Ferrini MG, Qian A, Rajfer J, Gonzalez-Cadavid NF . PDE L-arginine and PDE inhibitors counteract fibrosis in the Peyronie's fibrotic plaque and related fibroblast cultures. Nitric Oxide 2003; 9: 229–244.

    Article  CAS  Google Scholar 

  39. Shin HS, Bae SK, Lee MG . Pharmacokinetics of sildenafil after intravenous and oral administration in rats: hepatic and intestinal first-pass effects. Int J Pharm 2006; 320: 64–70.

    Article  CAS  Google Scholar 

  40. Orlandi A, Bochaton-Piallat ML, Gabbiani G, Spagnoli LG . Aging, smooth muscle cells and vascular pathobiology: implications for atherosclerosis. Atherosclerosis 2006; 188: 221–230.

    Article  CAS  Google Scholar 

  41. Musicki B, Champion HC, Becker RE, Kramer MF, Liu T, Sezen SF et al. In vivo analysis of chronic phosphodiesterase-5 inhibition with sildenafil in penile erectile tissues: no tachyphylaxis effect. J Urol 2005; 174: 1493–1496.

    Article  CAS  Google Scholar 

  42. Behr-Roussel D, Gorny D, Mevel K, Caisey S, Bernabe J, Burgess G et al. Chronic sildenafil improves erectile function and endothelium dependent cavernosal relaxations in rats: lack of tachyphylaxis. Eur Urol 2005; 47: 87–91.

    Article  CAS  Google Scholar 

  43. Musicki B, Champion HC, Becker RE, Liu T, Kramer MF, Burnett AL . Erection capability is potentiated by long-term sildenafil treatment: role of blood flow-induced endothelial nitric-oxide synthase phosphorylation. Mol Pharmacol 2005; 68: 226–232.

    CAS  PubMed  Google Scholar 

  44. Ghofrani HA, Osterloh IH, Grimminger F . Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond. Nat Rev Drug Discov 2006; 5: 689–702.

    Article  CAS  Google Scholar 

  45. Lu SY, Wang DS, Zhu MZ, Zhang QH, Hu YZ, Pei JM . Inhibition of hypoxia-induced proliferation and collagen synthesis by vasonatrin peptide in cultured rat pulmonary artery smooth muscle cells. Life Sci 2005; 77: 28–38.

    Article  CAS  Google Scholar 

  46. Rosanio S, Ye Y, Atar S, Rahman AM, Freeberg SY, Huang MH et al. Enhanced cardioprotection against ischemia-reperfusion injury with combining sildenafil with low-dose atorvastatin. Cardiovasc Drugs Ther 2006; 20: 27–36.

    Article  CAS  Google Scholar 

  47. Salloum F, Yin C, Xi L, Kukreja RC . Sildenafil induces delayed preconditioning through inducible nitric oxide synthase-dependent pathway in mouse heart. Circ Res 2003; 92: 595–597.

    Article  CAS  Google Scholar 

  48. Wharton J, Strange JW, Moller GM, Growcott EJ, Ren X, Franklyn AP et al. Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells. Am J Respir Crit Care Med 2005; 172: 105–113.

    Article  Google Scholar 

  49. Pilz RB, Casteel DE . Regulation of gene expression by cyclic GMP. Circ Res 2003; 93: 1034–1046.

    Article  CAS  Google Scholar 

  50. Ferrini MG, Nolazco G, Vernet D, Gonzalez-Cadavid NF, Berman J . Increased vaginal oxidative stress, apoptosis, and inducible nitric oxide synthase in a diabetic rat model: implications for vaginal fibrosis. Fertil Steril 2006; 86: 1152–1163.

    Article  CAS  Google Scholar 

  51. Smith Jr RS, Agata J, Xia CF, Chao L, Chao J . Human endothelial nitric oxide synthase gene delivery protects against cardiac remodeling and reduces oxidative stress after myocardial infarction. Life Sci 2005; 76: 2457–2471.

    Article  CAS  Google Scholar 

  52. Craven PA, Studer RK, Felder J, Phillips S, DeRubertis FR . Nitric oxide inhibition of transforming growth factor-beta and collagen synthesis in mesangial cells. Diabetes 1997; 46: 671–681.

    Article  CAS  Google Scholar 

  53. Lincoln TM, Wu X, Sellak H, Dey N, Choi CS . Regulation of vascular smooth muscle cell phenotype by cyclic GMP and cyclic GMP-dependent protein kinase. Front Biosci 2006; 11: 356–367.

    Article  CAS  Google Scholar 

  54. Desouza C, Parulkar A, Lumpkin D, Akers D, Fonseca VA . Acute and prolonged effects of sildenafil on brachial artery flow-mediated dilatation in type 2 diabetes. Diabetes Care 2002; 25: 1336–1339.

    Article  CAS  Google Scholar 

  55. Rosano GM, Aversa A, Vitale C, Fabbri A, Fini M, Spera G . Chronic treatment with tadalafil improves endothelial function in men with increased cardiovascular risk. Eur Urol 2005; 47: 214–220; discussion 220–222.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This study was funded by a grant from Pfizer Corp., and in part by grants from the National Institutes of Health (R01DK-53069 and G12RR-03026), and the Department of Defense (PC061300). Dr Monica Ferrini was partially funded by NIH grant 5P20MD000545

Author information

Authors and Affiliations

  1. LA Biomedical Research Institute at Harbor-UCLA Medical Center, Urology Research Laboratory, Torrance, CA, USA

    I Kovanecz, A Rambhatla, M Ferrini, D Vernet, S Sanchez, J Rajfer & N Gonzalez-Cadavid

  2. David Geffen School of Medicine at UCLA, Los Angeles, CA, USA

    M Ferrini, J Rajfer & N Gonzalez-Cadavid

  3. Division of Urology, Harbour-UCLA Medical Center, Torrance, CA, USA

    J Rajfer & N Gonzalez-Cadavid

Authors
  1. I Kovanecz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A Rambhatla
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M Ferrini
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D Vernet
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S Sanchez
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J Rajfer
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. N Gonzalez-Cadavid
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to N Gonzalez-Cadavid.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kovanecz, I., Rambhatla, A., Ferrini, M. et al. Long-term continuous sildenafil treatment ameliorates corporal veno-occlusive dysfunction (CVOD) induced by cavernosal nerve resection in rats. Int J Impot Res 20, 202–212 (2008). https://doi.org/10.1038/sj.ijir.3901612

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijir.3901612

Keywords

This article is cited by

Search

Advanced search

Quick links